| 产品描述: | BPR1R024 is an orally active and selective colony-stimulating factor-1 receptor (CSF1R) inhibitor. BPR1R024 has potent CSF1R inhibition activity with an IC50 value of 0.53 nM. BPR1R024 can be used for the research of immuno-oncology. |
| 体外研究: |
BPR1R024 (compound 12) (oral; 100 mg/kg; twice a day) exhibits antitumor and immunomodulatory activity in a murine colon tumor model. |
| 体内研究: |
BPR1R024 (compound 12) has potent CSF1R inhibition activity with an IC50 value of 0.53 nM. BPR1R024 exhibits weake AURA and AURB inhibitory activity in enzyme activity assay with IC50 values of >10 μM and 1.40 μM, respeactively. BPR1R024 (0-500 nM) significantly suppressed the CSF1R signal in a dose-dependent manner. BPR1R024 (10 nM, 100 nM) inhibits CSF1/CSF1R signaling-mediated TNF-α production. BPR1R024 (0-10 μM) specifically inhibits protumor M2-like macrophage survival with a minimal effect on antitumor M1-like macrophage growth. |
| 参考文献: |
1. Lee KH, et al. Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model. J Med Chem. 2021 Oct 14;64(19):14477-14497. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.073 ml |
10.364 ml |
20.727 ml |
| 5 mM |
0.415 ml |
2.073 ml |
4.145 ml |
| 10 mM |
0.207 ml |
1.036 ml |
2.073 ml |
| 50 mM |
0.041 ml |
0.207 ml |
0.415 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |